Alnylam Pharmaceuticals (ALNY) P/B ratio

P/B ratio today
26.7×

Alnylam Pharmaceuticals (ALNY) trades at 26.7× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 67.9×. That is 84.8% lower than the 447.7× of fiscal 2024. Figures as of 18 Nov 2026, 09:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
26.7×
P/B ratio, fiscal 2025
67.9×
Change on fiscal 2024
−84.8%
Highest on record
447.7×fiscal 2024
Lowest on record
8.7×fiscal 2019
Fiscal years on record
52019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Alnylam Pharmaceuticals P/B ratio, in more detail

Today's figure is 60.6% below the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2019–2025), the highest was 447.7× in fiscal 2024 and the lowest 8.7× in fiscal 2019. Today's P/B ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 34.1×.

History · 5 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Alnylam Pharmaceuticals P/B ratio, year by year

Alnylam Pharmaceuticals (ALNY) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today26.7×—$156.50—
202567.9× 84.8% down$397.65$5.86
2024447.7×—$235.31$0.53
2023——$191.41-$1.77
2022——$237.65-$1.30
202134.1× 132.2% up$169.58$4.97
202014.7× 68.1% up$129.97$8.84
20198.7×—$115.17$13.17
2018——$72.91—
2017——$127.05—
2016——$37.44—
2015——$94.14—
2014——$97.00—
2013——$64.30—
2012——$18.25—
2011——$8.15—
2010——$9.86—
2009——$17.62—
2008——$24.73—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Alnylam Pharmaceuticals and comparable companies
CompanyP/B ratio
Tenet Healthcare THC5.3×
Alnylam Pharmaceuticals ALNY26.6×
Zimmer Biomet Holdings ZBH1.5×
Medpace Holdings MEDP39.8×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals P/B ratio: questions and answers

What is Alnylam Pharmaceuticals's P/B ratio?

Alnylam Pharmaceuticals (ALNY) trades at 26.7× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 67.9×. That is 84.8% lower than the 447.7× of fiscal 2024.

Is Alnylam Pharmaceuticals's P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 34.1×.

What are the highest and lowest P/B ratio figures on record for Alnylam Pharmaceuticals?

Across the 5 fiscal year-ends on record (2019–2025), the highest was 447.7× in fiscal 2024 and the lowest 8.7× in fiscal 2019.

How is Alnylam Pharmaceuticals's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Alnylam Pharmaceuticals it is on record here for 5 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ALNY/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.